Cargando…

TBIO-18. ESTABLISHING A PIPELINE FOR INDIVIDUALIZED TREATMENT OPTIONS FOR PEDIATRIC BRAIN CANCER

INTRODUCTION: Despite being able to characterize pediatric brain tumors such as medulloblastoma and high-grade gliomas using detailed molecular analysis tools, this knowledge hasn’t been translated to better treatment methods. In this project, we aim to create a biobank of pediatric brain tumors (PB...

Descripción completa

Detalles Bibliográficos
Autores principales:	Djirackor, Luna, Halldorsson, Skarphedinn, Sandberg, Cecilie, Euskirchen, Philipp, Skaga, Erlend, Kulesskiy, Evgeny, Wennerberg, Krister, Langmoen, Iver, Vik-Mo, Einar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Tumor Biology (not fitting a specific disease category)
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715180/ http://dx.doi.org/10.1093/neuonc/noaa222.845

Ejemplares similares

TBIO-03. Angiogenesis in Pituitary Adenoma
por: Yoshida, Daizo, et al.
Publicado: (2022)

TBIO-27. RASOPATHIES AND BRAIN TUMOROGENESIS: ARE SOS1 MUTATIONS ARE CONCERNED?
por: Abdelmoula, Nouha Bouayed, et al.
Publicado: (2020)

TBIO-09. EZHIP is not expressed within the developing mouse or human brain
por: Talal Younes, Subhi, et al.
Publicado: (2022)

TBIO-01. SEX DIFFERENCES IN REDOX STATE UNDERLIE GLUTAMINE DEPENDENCY IN MALE GLIOBLASTOMA
por: Sponagel, Jasmin, et al.
Publicado: (2020)

TBIO-24. USING MOLECULAR GUIDED THERAPY IN PEDIATRIC NEURO ONCOLOGY PATIENTS: THE SUCCESS AND BARRIERS
por: Armstrong, Beth, et al.
Publicado: (2020)

TBIO-19. INTEGRATED GENOMIC, PROTEOMIC AND PHOSPHOPROTEOMIC ANALYSIS OF SEVEN TYPES OF PEDIATRIC BRAIN CANCER
por: Petralia, Francesca, et al.
Publicado: (2020)

TBIO-06. BDNF-TRKB SIGNALING REGULATES NEURON-GLIOMA SYNAPTOGENESIS AND PROMOTES TUMOR PROGRESSION
por: Taylor, Kathryn, et al.
Publicado: (2020)

TBIO-02. Mapping the origins of pediatric brain tumors to cell type lineages in the developing cerebellum.
por: Okonechnikov, Konstantin, et al.
Publicado: (2022)

TBIO-01. Mutation Profiling of Paediatric Solid Tumours in a Cohort of South African Patients
por: Lamola, Lindiwe, et al.
Publicado: (2022)

TBIO-07. Pediatric tumor classification through genome-wide methylation profiling of extracellular vesicle DNA
por: Ricklefs, Franz, et al.
Publicado: (2022)

TBIO-26. NON-CANONICAL OPEN READING FRAMES ENCODE FUNCTIONAL PROTEINS ESSENTIAL FOR CANCER CELL SURVIVAL
por: Prensner, John, et al.
Publicado: (2020)

TBIO-12. THE SPECTRUM OF MITOCHONDRIAl DNA (mtDNA) MUTATIONS IN PEDIATRIC CENTRAL NERVOUS SYSTEM (CNS) TUMORS
por: Kaneva, Kristiyana, et al.
Publicado: (2020)

TBIO-13. USE OF NEXT GENERATION SEQUENCING TO IDENTIFY MOVE DRIVERS OF CRYPTIC, CLINICALLY AGGRESSIVE BRAIN TUMORS
por: Younes, Subhi Talal, et al.
Publicado: (2020)

TBIO-17. INTEGRATIVE ANALYSES OF BRAFv600e MUTATED GLIOMAS: FROM MOLECULAR BIOLOGY TO RADIOLOGY AND TREATMENTS
por: Lhermitte, Benoit, et al.
Publicado: (2020)

TBIO-14. CHARACTERISATION OF THE ARGININE PATHWAY ENZYMES IN PAEDIATRIC BRAIN TUMOURS TO DETERMINE SUSCEPTIBILITY TO THERAPEUTIC ARGININE DEPLETION
por: Bishop, Eleanor, et al.
Publicado: (2020)

TBIO-05. GENOME-SCALE NUCLEOTIDE-SPECIFIC CHARACTERIZATION OF 5-HYDROXYMETHYLCYTOSINE IN PEDIATRIC CENTRAL NERVOUS SYSTEM TUMORS
por: Azizgolshani, Nasim, et al.
Publicado: (2020)

TBIO-12. Screening for Cancer Predisposition Syndromes in Pediatric Neuro-Oncology Patients: a Single Institution Experience
por: Johns, Claire, et al.
Publicado: (2022)

TBIO-03. THE GIFT FROM A CHILD PROGRAM IS EMPOWERING POST-MORTEM TISSUE DONATION ACROSS THE UNITED STATES
por: Waanders, Angela, et al.
Publicado: (2020)

TBIO-09. IN SILICO ANALYSIS IDENTIFIES A PUTATIVE CELL-OF-ORIGIN FOR BRAF FUSION-POSITIVE CEREBELLAR PILOCYTIC ASTROCYTOMA
por: Younes, Subhi Talal
Publicado: (2020)

TBIO-15. MODELING DEVELOPMENTAL GENE EXPRESSION DYNAMICS AT CELLULAR RESOLUTION TO INTERPRET PEDIATRIC BRAIN TUMOR TRANSCRIPTIONAL PROGRAMS
por: Jessa, Selin, et al.
Publicado: (2020)

Feasibility study of using high-throughput drug sensitivity testing to target recurrent glioblastoma stem cells for individualized treatment
por: Skaga, Erlend, et al.
Publicado: (2019)

TBIO-16. NOTCH1 PATHWAY AS TARGET FOR DRUG INTERVENTION FOR HISTONE 3 G34R MUTATED pHGG
por: Foot, Katie, et al.
Publicado: (2020)

TBIO-11. DEEP LEARNING-BASED SINGLE-CELL RNA SEQUENCING DIFFERENTIATION IDENTIFIES SIMPLE AND COMPLEX TRANSCRIPTIONAL NETWORKS FOR SUBPOPULATION CLASSIFICATION
por: Prince, Eric, et al.
Publicado: (2020)

TBIO-07. SINGLE-CELL TRANSCRIPTOMIC PROFILE REVEALS MACROPHAGE HETEROGENEITY IN SONIC-HEDGEHOG MEDULLOBLASTOMA AND THEIR DISTINCT RESPONSES TO DIFFERENT TREATMENT MODALITIES
por: Dang, Mai, et al.
Publicado: (2020)

TBIO-02. IMMUNE PROFILING OF RARE EMBRYONAL BRAIN TUMORS REVEAL EVIDENCE OF DYSREGULATED INTERFERON SIGNALLING AS A POTENTIAL DETERMINANT OF IMMUNOLOGICAL HETEROGENEITY
por: Popovski, Dean, et al.
Publicado: (2020)

Intertumoral heterogeneity in patient-specific drug sensitivities in treatment-naïve glioblastoma
por: Skaga, Erlend, et al.
Publicado: (2019)

Functional temozolomide sensitivity testing of patient-specific glioblastoma stem cell cultures is predictive of clinical outcome
por: Skaga, Erlend, et al.
Publicado: (2022)

EPCT-15. RAPID EPIGENOMIC CLASSIFICATION OF BRAIN TUMORS ENABLES INTRAOPERATIVE NEUROSURGICAL RISK MODULATION
por: Djirackor, Luna, et al.
Publicado: (2021)

TBIO-08. BASE-RESOLUTION METHYLOMES OF GLIOMAS BEARING HISTONE H3.3 MUTATIONS REVEAL A G34 MUTANT-SPECIFIC SIGNATURE SHARED WITH BONE TUMORS
por: Sangatsuda, Yuhei, et al.
Publicado: (2020)

TBIO-21. Lnc-TALC PROMOTES O(6)-METHYLGUANINE-DNA METHYLTRANSFERASE EXPRESSION VIA REGULATING THE C-MET PATHWAY BY COMPETITIVELY BINDING WITH miR-20b-3p
por: Wu, Pengfei, et al.
Publicado: (2020)

Intraoperative DNA methylation classification of brain tumors impacts neurosurgical strategy
por: Djirackor, Luna, et al.
Publicado: (2021)

The efficacy of a coordinated pharmacological blockade in glioblastoma stem cells with nine repurposed drugs using the CUSP9 strategy
por: Skaga, Erlend, et al.
Publicado: (2019)

Phenotypic and Expressional Heterogeneity in the Invasive Glioma Cells()()
por: Fayzullin, Artem, et al.
Publicado: (2018)

A Small-Molecule Tankyrase Inhibitor Reduces Glioma Stem Cell Proliferation and Sphere Formation
por: Kierulf-Vieira, Kirsten Strømme, et al.
Publicado: (2020)

Real-world validity of randomized controlled phase III trials in newly diagnosed glioblastoma: to whom do the results of the trials apply?
por: Skaga, Erlend, et al.
Publicado: (2021)

Transcriptional Profiling of Adult Neural Stem-Like Cells from the Human Brain
por: Sandberg, Cecilie Jonsgar, et al.
Publicado: (2014)

Aqp 9 and Brain Tumour Stem Cells
por: Fossdal, Guri, et al.
Publicado: (2012)

Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells
por: Stangeland, Biljana, et al.
Publicado: (2015)

OTHR-02. MULTIMODALITY TREATMENT FOR CHILDREN WITH CENTRAL NERVOUS SYSTEM (CNS) TUMOR IN OUR INSTITUTE
por: Sasano, Mari, et al.
Publicado: (2020)

OTHR-09. CENTRAL DIABETES INSIPIDUS: A RARE UNREPORTED SIDE EFFECT OF TEMOZOLOMIDE IN PEDIATRICS
por: Kuo, Christopher, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0kb7arl4b6fh2o9cmorf7384op